| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase Type III | 39 | 2024 | 706 | 3.310 |
Why?
|
| Nitric Oxide Synthase | 25 | 2008 | 911 | 1.930 |
Why?
|
| Nitric Oxide | 33 | 2022 | 2146 | 1.680 |
Why?
|
| Nitric Oxide Synthase Type I | 17 | 2019 | 175 | 0.910 |
Why?
|
| Brain Ischemia | 11 | 2016 | 3007 | 0.830 |
Why?
|
| Endothelium, Vascular | 15 | 2018 | 4427 | 0.770 |
Why?
|
| Nitric Oxide Synthase Type II | 19 | 2009 | 514 | 0.770 |
Why?
|
| Mice, Knockout | 48 | 2022 | 14488 | 0.590 |
Why?
|
| Ischemic Preconditioning | 4 | 2008 | 89 | 0.550 |
Why?
|
| Nitric Oxide Donors | 3 | 2016 | 126 | 0.550 |
Why?
|
| Cerebrovascular Circulation | 11 | 2024 | 2725 | 0.510 |
Why?
|
| Reperfusion Injury | 4 | 2019 | 1039 | 0.490 |
Why?
|
| Apolipoproteins E | 11 | 2014 | 1461 | 0.470 |
Why?
|
| Infarction, Middle Cerebral Artery | 6 | 2024 | 486 | 0.470 |
Why?
|
| Oximes | 1 | 2016 | 303 | 0.460 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 440 | 0.450 |
Why?
|
| Ischemic Postconditioning | 1 | 2014 | 24 | 0.450 |
Why?
|
| Quinoxalines | 1 | 2016 | 297 | 0.450 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2014 | 483 | 0.440 |
Why?
|
| Diabetes Complications | 2 | 2013 | 1320 | 0.420 |
Why?
|
| Regional Blood Flow | 3 | 2011 | 1500 | 0.410 |
Why?
|
| Myocardial Reperfusion | 1 | 2014 | 339 | 0.410 |
Why?
|
| Hyperlipidemias | 3 | 2018 | 772 | 0.400 |
Why?
|
| Mutant Proteins | 1 | 2014 | 488 | 0.390 |
Why?
|
| Serine | 3 | 2013 | 831 | 0.390 |
Why?
|
| Mice | 68 | 2024 | 82029 | 0.360 |
Why?
|
| Phosphorylation | 12 | 2024 | 8317 | 0.360 |
Why?
|
| Insulin Resistance | 7 | 2018 | 3986 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 35 | 2024 | 22379 | 0.360 |
Why?
|
| Blood Vessels | 4 | 2012 | 1110 | 0.330 |
Why?
|
| Electrocardiography | 6 | 2022 | 6412 | 0.310 |
Why?
|
| Animals | 76 | 2024 | 169246 | 0.300 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 461 | 0.300 |
Why?
|
| Endothelium | 1 | 2010 | 768 | 0.290 |
Why?
|
| Atherosclerosis | 9 | 2012 | 3433 | 0.270 |
Why?
|
| Cerebral Infarction | 4 | 2019 | 969 | 0.270 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2008 | 241 | 0.260 |
Why?
|
| Genetic Loci | 4 | 2020 | 2629 | 0.260 |
Why?
|
| Gene Deletion | 2 | 2004 | 2675 | 0.250 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2019 | 1493 | 0.240 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1162 | 0.240 |
Why?
|
| Tunica Intima | 3 | 2009 | 459 | 0.240 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 18349 | 0.240 |
Why?
|
| Arteriosclerosis | 3 | 2004 | 1055 | 0.230 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2003 | 93 | 0.230 |
Why?
|
| Olea | 1 | 2003 | 3 | 0.220 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2003 | 42 | 0.220 |
Why?
|
| Stroke | 8 | 2024 | 9755 | 0.220 |
Why?
|
| Infrared Rays | 1 | 2005 | 249 | 0.220 |
Why?
|
| Body Height | 2 | 2022 | 1565 | 0.220 |
Why?
|
| Molecular Probes | 1 | 2005 | 309 | 0.220 |
Why?
|
| Weightlessness | 1 | 2003 | 103 | 0.210 |
Why?
|
| Adiposity | 1 | 2013 | 1895 | 0.210 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 393 | 0.200 |
Why?
|
| Myocardium | 7 | 2018 | 4788 | 0.200 |
Why?
|
| Quantitative Trait Loci | 6 | 2020 | 2131 | 0.190 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 2258 | 0.190 |
Why?
|
| Leukocytes | 4 | 2015 | 2035 | 0.190 |
Why?
|
| Genetic Variation | 6 | 2020 | 6611 | 0.190 |
Why?
|
| Receptors, IgG | 2 | 2016 | 564 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 702 | 0.180 |
Why?
|
| Space Flight | 1 | 2003 | 219 | 0.180 |
Why?
|
| Crosses, Genetic | 4 | 2013 | 752 | 0.180 |
Why?
|
| Arginine | 3 | 2003 | 932 | 0.180 |
Why?
|
| Hypotension, Orthostatic | 1 | 2003 | 258 | 0.180 |
Why?
|
| Mice, Transgenic | 9 | 2019 | 9561 | 0.170 |
Why?
|
| Hyperbaric Oxygenation | 4 | 2011 | 166 | 0.170 |
Why?
|
| Hyperoxia | 2 | 2014 | 261 | 0.170 |
Why?
|
| Oxidative Stress | 7 | 2014 | 3139 | 0.160 |
Why?
|
| Delta Rhythm | 1 | 2019 | 81 | 0.160 |
Why?
|
| Gene Frequency | 4 | 2022 | 3623 | 0.160 |
Why?
|
| Sodium Nitrite | 1 | 2018 | 16 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 1124 | 0.160 |
Why?
|
| Blood-Brain Barrier | 3 | 2016 | 1034 | 0.160 |
Why?
|
| Hypertension | 6 | 2018 | 8616 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2012 | 1169 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 707 | 0.150 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 3109 | 0.150 |
Why?
|
| Tyrosine | 1 | 2003 | 1427 | 0.150 |
Why?
|
| Cytoprotection | 3 | 2014 | 200 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 12252 | 0.150 |
Why?
|
| Insulin | 4 | 2016 | 6607 | 0.140 |
Why?
|
| Blood Volume | 2 | 2013 | 545 | 0.140 |
Why?
|
| Somatostatin | 1 | 2019 | 458 | 0.140 |
Why?
|
| Connexin 43 | 1 | 2018 | 202 | 0.140 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2018 | 153 | 0.140 |
Why?
|
| Blood Pressure | 8 | 2018 | 8543 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2008 | 1165 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2022 | 2457 | 0.130 |
Why?
|
| Losartan | 1 | 2018 | 262 | 0.130 |
Why?
|
| Juxtaglomerular Apparatus | 1 | 2015 | 14 | 0.130 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2013 | 56 | 0.130 |
Why?
|
| Platelet Aggregation | 2 | 2013 | 769 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.130 |
Why?
|
| Hypogonadism | 1 | 2002 | 805 | 0.130 |
Why?
|
| Marfan Syndrome | 1 | 2018 | 237 | 0.130 |
Why?
|
| Vascular Resistance | 2 | 2013 | 939 | 0.130 |
Why?
|
| Superoxides | 3 | 2013 | 389 | 0.130 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 5176 | 0.130 |
Why?
|
| Brain Infarction | 2 | 2016 | 286 | 0.130 |
Why?
|
| Infertility | 1 | 2002 | 655 | 0.120 |
Why?
|
| Aorta | 5 | 2016 | 2045 | 0.120 |
Why?
|
| Glucose | 4 | 2018 | 4352 | 0.120 |
Why?
|
| Endothelial Cells | 7 | 2022 | 3589 | 0.120 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 4620 | 0.110 |
Why?
|
| Obesity | 3 | 2018 | 13090 | 0.110 |
Why?
|
| Penile Erection | 2 | 2006 | 100 | 0.110 |
Why?
|
| rho-Associated Kinases | 2 | 2013 | 290 | 0.110 |
Why?
|
| Permeability | 1 | 2016 | 725 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2015 | 4035 | 0.110 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 399 | 0.110 |
Why?
|
| Cyclic GMP | 3 | 2011 | 394 | 0.110 |
Why?
|
| Cerebral Cortex | 4 | 2019 | 5812 | 0.110 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2015 | 301 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2013 | 596 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2018 | 472 | 0.110 |
Why?
|
| Penis | 2 | 2006 | 209 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 896 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1009 | 0.100 |
Why?
|
| Motor Skills | 1 | 2016 | 523 | 0.100 |
Why?
|
| Brain | 5 | 2013 | 27360 | 0.100 |
Why?
|
| Nitrites | 1 | 2013 | 156 | 0.100 |
Why?
|
| Signal Transduction | 12 | 2022 | 23645 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2014 | 147 | 0.100 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 12795 | 0.100 |
Why?
|
| Mitochondria, Heart | 2 | 2011 | 236 | 0.100 |
Why?
|
| Male | 37 | 2022 | 364719 | 0.100 |
Why?
|
| Myocardial Contraction | 3 | 2008 | 1525 | 0.100 |
Why?
|
| Up-Regulation | 6 | 2009 | 4146 | 0.100 |
Why?
|
| Immunohistochemistry | 10 | 2014 | 11095 | 0.100 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 1040 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2005 | 633 | 0.100 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 15662 | 0.090 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 271 | 0.090 |
Why?
|
| Nitrates | 1 | 2013 | 260 | 0.090 |
Why?
|
| Homeostasis | 3 | 2018 | 3348 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 422 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2016 | 4978 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3590 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2013 | 2479 | 0.090 |
Why?
|
| Thrombospondins | 1 | 2011 | 196 | 0.090 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 370 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2011 | 238 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2022 | 16045 | 0.090 |
Why?
|
| Paraplegia | 1 | 2011 | 161 | 0.090 |
Why?
|
| Spinal Cord Ischemia | 1 | 2011 | 94 | 0.090 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2009 | 28 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2010 | 3096 | 0.090 |
Why?
|
| Energy Intake | 1 | 2017 | 2146 | 0.080 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2009 | 86 | 0.080 |
Why?
|
| Memory | 1 | 2019 | 2208 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 572 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2014 | 1209 | 0.080 |
Why?
|
| Guanylate Cyclase | 1 | 2010 | 206 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 435 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2011 | 730 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2014 | 1534 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2009 | 125 | 0.080 |
Why?
|
| Cadherins | 1 | 2013 | 905 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2017 | 2907 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4580 | 0.080 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2008 | 21 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2015 | 1344 | 0.080 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 317 | 0.080 |
Why?
|
| Oxygen | 4 | 2022 | 4270 | 0.070 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 375 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2016 | 5403 | 0.070 |
Why?
|
| Magnetics | 1 | 2011 | 597 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 201 | 0.070 |
Why?
|
| Gene Expression | 4 | 2020 | 7598 | 0.070 |
Why?
|
| Reactive Oxygen Species | 4 | 2013 | 2149 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2009 | 394 | 0.070 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2009 | 165 | 0.070 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1617 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2008 | 109 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2014 | 5027 | 0.070 |
Why?
|
| Malondialdehyde | 2 | 2008 | 113 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 4573 | 0.070 |
Why?
|
| Globins | 1 | 2008 | 405 | 0.070 |
Why?
|
| Adipokines | 1 | 2009 | 309 | 0.070 |
Why?
|
| Enzyme Inhibitors | 6 | 2011 | 3728 | 0.070 |
Why?
|
| Sarcolemma | 2 | 2003 | 66 | 0.070 |
Why?
|
| Heart | 4 | 2010 | 4446 | 0.070 |
Why?
|
| Water | 1 | 2013 | 1421 | 0.070 |
Why?
|
| Humans | 37 | 2022 | 768166 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2006 | 262 | 0.070 |
Why?
|
| Aldosterone | 1 | 2011 | 881 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 3 | 2011 | 2631 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2005 | 461 | 0.070 |
Why?
|
| Kinetics | 1 | 2014 | 6329 | 0.070 |
Why?
|
| Motor Neurons | 1 | 2011 | 870 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 2429 | 0.060 |
Why?
|
| Isoenzymes | 4 | 2003 | 1688 | 0.060 |
Why?
|
| Dietary Fats | 3 | 2013 | 2003 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1743 | 0.060 |
Why?
|
| HIV-1 | 1 | 2003 | 6961 | 0.060 |
Why?
|
| Heart Rate | 1 | 2017 | 4214 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2011 | 1191 | 0.060 |
Why?
|
| Ion Transport | 2 | 2003 | 322 | 0.060 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1681 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2020 | 18065 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 359 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2015 | 1595 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 93 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 488 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 577 | 0.060 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 111 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2016 | 3858 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2009 | 1105 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 1369 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2011 | 662 | 0.060 |
Why?
|
| Alanine | 1 | 2007 | 614 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2011 | 2363 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2022 | 19015 | 0.060 |
Why?
|
| Tyramine | 1 | 2003 | 55 | 0.060 |
Why?
|
| Ischemia | 4 | 2011 | 1900 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2005 | 281 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 152 | 0.060 |
Why?
|
| Drug Design | 1 | 2009 | 1046 | 0.060 |
Why?
|
| Chromogranin A | 1 | 2003 | 47 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 625 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11519 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2011 | 1276 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1805 | 0.060 |
Why?
|
| Adenine | 1 | 2009 | 995 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2011 | 873 | 0.060 |
Why?
|
| Endothelins | 1 | 2003 | 127 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 1281 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2003 | 125 | 0.060 |
Why?
|
| Mutation | 4 | 2013 | 30238 | 0.050 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 575 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2003 | 98 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2015 | 2401 | 0.050 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2003 | 45 | 0.050 |
Why?
|
| Supine Position | 1 | 2003 | 208 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 797 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2014 | 6004 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2003 | 292 | 0.050 |
Why?
|
| Chromogranins | 1 | 2003 | 160 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2018 | 13053 | 0.050 |
Why?
|
| Stem Cells | 2 | 2009 | 3537 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2003 | 177 | 0.050 |
Why?
|
| Plant Leaves | 1 | 2003 | 153 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2003 | 165 | 0.050 |
Why?
|
| Simvastatin | 1 | 2005 | 346 | 0.050 |
Why?
|
| Telencephalon | 1 | 2003 | 143 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2004 | 251 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 216 | 0.050 |
Why?
|
| Baroreflex | 1 | 2003 | 154 | 0.050 |
Why?
|
| Perfusion | 2 | 2005 | 1401 | 0.050 |
Why?
|
| Weight Gain | 1 | 2013 | 2359 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2006 | 1081 | 0.050 |
Why?
|
| Cathepsin B | 1 | 2002 | 80 | 0.050 |
Why?
|
| Hematocrit | 1 | 2003 | 623 | 0.050 |
Why?
|
| Citrulline | 1 | 2002 | 107 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2005 | 559 | 0.050 |
Why?
|
| Fasting | 2 | 2018 | 1610 | 0.050 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 863 | 0.050 |
Why?
|
| P-Selectin | 1 | 2004 | 598 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 898 | 0.050 |
Why?
|
| Arterioles | 1 | 2002 | 251 | 0.050 |
Why?
|
| Cell Division | 2 | 2009 | 4473 | 0.050 |
Why?
|
| Syncope | 1 | 2003 | 430 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2002 | 244 | 0.040 |
Why?
|
| Phenotype | 4 | 2022 | 16726 | 0.040 |
Why?
|
| Contrast Media | 1 | 2014 | 5330 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9538 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 2145 | 0.040 |
Why?
|
| Exons | 2 | 2006 | 2394 | 0.040 |
Why?
|
| Microcirculation | 2 | 2022 | 1281 | 0.040 |
Why?
|
| Organ Size | 2 | 2002 | 2267 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2138 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2009 | 2575 | 0.040 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 1422 | 0.040 |
Why?
|
| Mitochondria | 2 | 2014 | 3681 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1252 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 727 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2020 | 128 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2003 | 497 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2002 | 822 | 0.040 |
Why?
|
| Tomography | 1 | 2002 | 442 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 996 | 0.040 |
Why?
|
| Choroid | 1 | 2002 | 364 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2055 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2014 | 6229 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2013 | 693 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8744 | 0.040 |
Why?
|
| Rats | 8 | 2011 | 23760 | 0.040 |
Why?
|
| Sample Size | 1 | 2022 | 846 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 797 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2008 | 2418 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3800 | 0.040 |
Why?
|
| Genotype | 3 | 2017 | 13045 | 0.040 |
Why?
|
| Time Factors | 6 | 2018 | 40218 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 404 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 744 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 3941 | 0.040 |
Why?
|
| Hormones | 1 | 2002 | 866 | 0.040 |
Why?
|
| Protective Agents | 2 | 2013 | 150 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2020 | 259 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 702 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2003 | 866 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 965 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1944 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2957 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 1997 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2010 | 10474 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Neurons | 3 | 2019 | 9514 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5703 | 0.030 |
Why?
|
| Rats, Inbred SHR | 2 | 2008 | 186 | 0.030 |
Why?
|
| Luminescent Measurements | 2 | 2013 | 342 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1930 | 0.030 |
Why?
|
| Genome, Human | 2 | 2022 | 4446 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2003 | 1224 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2009 | 2650 | 0.030 |
Why?
|
| Antiporters | 1 | 2018 | 276 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9263 | 0.030 |
Why?
|
| Somatomedins | 1 | 2017 | 179 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2892 | 0.030 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 320 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2009 | 161 | 0.030 |
Why?
|
| Haplotypes | 1 | 2022 | 2722 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 2202 | 0.030 |
Why?
|
| Retinal Vessels | 1 | 2002 | 864 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 13671 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6894 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2013 | 2004 | 0.030 |
Why?
|
| Female | 15 | 2020 | 397192 | 0.030 |
Why?
|
| Antihypertensive Agents | 3 | 2018 | 2029 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2011 | 12800 | 0.030 |
Why?
|
| Europe | 1 | 2022 | 3436 | 0.030 |
Why?
|
| Virus Replication | 1 | 2003 | 2458 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2018 | 428 | 0.030 |
Why?
|
| Neutrophils | 2 | 2005 | 3786 | 0.030 |
Why?
|
| omega-N-Methylarginine | 2 | 2005 | 108 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1966 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2633 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2018 | 818 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 90 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2018 | 4030 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2004 | 3655 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 1567 | 0.030 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 15597 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 611 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 65371 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2013 | 55 | 0.030 |
Why?
|
| Time | 2 | 2008 | 552 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 11928 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 809 | 0.030 |
Why?
|
| Cholesterol | 1 | 2003 | 2914 | 0.030 |
Why?
|
| Dystrophin | 1 | 2014 | 284 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2013 | 90 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1338 | 0.030 |
Why?
|
| Motor Activity | 1 | 2003 | 2711 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 406 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2020 | 12168 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2013 | 199 | 0.030 |
Why?
|
| Risk Factors | 4 | 2017 | 74944 | 0.030 |
Why?
|
| Ligation | 2 | 2004 | 446 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 4352 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 414 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
| Models, Biological | 3 | 2018 | 9495 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2011 | 46 | 0.020 |
Why?
|
| Biological Transport | 1 | 2016 | 2085 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3272 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 606 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2011 | 305 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2002 | 3124 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3533 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2013 | 539 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 1613 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 1089 | 0.020 |
Why?
|
| Cattle | 1 | 2016 | 3819 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 3251 | 0.020 |
Why?
|
| Seizures | 1 | 2003 | 2998 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 1513 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2003 | 480 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2013 | 772 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 669 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1656 | 0.020 |
Why?
|
| Adult | 6 | 2018 | 223646 | 0.020 |
Why?
|
| Troponin I | 1 | 2014 | 662 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1760 | 0.020 |
Why?
|
| Vasculitis | 1 | 2013 | 525 | 0.020 |
Why?
|
| Reperfusion | 1 | 2010 | 266 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2022 | 3591 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2017 | 2202 | 0.020 |
Why?
|
| Microdissection | 1 | 2009 | 150 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2006 | 1741 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 424 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2732 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 845 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 611 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 585 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2009 | 705 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2019 | 6314 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 740 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 1968 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1951 | 0.020 |
Why?
|
| Virus Integration | 1 | 2009 | 307 | 0.020 |
Why?
|
| Kidney | 1 | 2003 | 7064 | 0.020 |
Why?
|
| Middle Aged | 5 | 2018 | 223492 | 0.020 |
Why?
|
| Spironolactone | 1 | 2011 | 415 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 1880 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 699 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2008 | 213 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 11879 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 36743 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 305 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 259 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13676 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8128 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 967 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 2006 | 139 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 1597 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1751 | 0.020 |
Why?
|
| Fibrinolysin | 1 | 2005 | 130 | 0.020 |
Why?
|
| Neuroglia | 1 | 2011 | 960 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1340 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 931 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2009 | 725 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 1951 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 1960 | 0.010 |
Why?
|
| Calcium | 3 | 2002 | 5792 | 0.010 |
Why?
|
| Hydrogen | 1 | 2005 | 171 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1754 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2862 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2006 | 629 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 216 | 0.010 |
Why?
|
| Cytokines | 2 | 2013 | 7453 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3055 | 0.010 |
Why?
|
| Tail | 1 | 2004 | 91 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2003 | 49 | 0.010 |
Why?
|
| Intracranial Embolism | 1 | 2005 | 188 | 0.010 |
Why?
|
| Bacteroidaceae Infections | 1 | 2003 | 32 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 1738 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 158 | 0.010 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 40 | 0.010 |
Why?
|
| Sleep | 1 | 2019 | 4819 | 0.010 |
Why?
|
| Lymphography | 1 | 2004 | 189 | 0.010 |
Why?
|
| Nitroarginine | 1 | 2003 | 66 | 0.010 |
Why?
|
| Heptanoic Acids | 1 | 2005 | 344 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2003 | 323 | 0.010 |
Why?
|
| Microdialysis | 1 | 2003 | 156 | 0.010 |
Why?
|
| Acridines | 1 | 2002 | 18 | 0.010 |
Why?
|
| Rheology | 1 | 2004 | 348 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 328 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1730 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6009 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8509 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6514 | 0.010 |
Why?
|
| Equipment Design | 1 | 2011 | 3522 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2009 | 2204 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 6568 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1765 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2002 | 24 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2002 | 122 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Hydralazine | 1 | 2002 | 34 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2002 | 52 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.010 |
Why?
|
| Bruch Membrane | 1 | 2002 | 65 | 0.010 |
Why?
|
| Partial Pressure | 1 | 2002 | 248 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4283 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 990 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1250 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2002 | 164 | 0.010 |
Why?
|
| Hyperemia | 1 | 2003 | 224 | 0.010 |
Why?
|
| Caveolins | 1 | 2002 | 102 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2002 | 75 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 398 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2009 | 3956 | 0.010 |
Why?
|
| Fetus | 1 | 2009 | 1883 | 0.010 |
Why?
|
| Carbachol | 1 | 2002 | 223 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1485 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11669 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 816 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 388 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 765 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5777 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2002 | 185 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2002 | 325 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2003 | 597 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 347 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9615 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22291 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2008 | 1862 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 2627 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2013 | 3445 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2002 | 592 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2003 | 1353 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20227 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5799 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6283 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2937 | 0.010 |
Why?
|
| Pyrroles | 1 | 2005 | 1124 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15454 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 592 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 12421 | 0.010 |
Why?
|
| Capillaries | 1 | 2002 | 755 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2005 | 958 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 762 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2002 | 942 | 0.010 |
Why?
|
| Wound Healing | 1 | 2009 | 2809 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1888 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2003 | 1179 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 3623 | 0.010 |
Why?
|
| Lasers | 1 | 2002 | 952 | 0.010 |
Why?
|
| Skin | 1 | 2011 | 4503 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 1479 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15948 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 7243 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 17569 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2002 | 856 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 2227 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 981 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1515 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 2064 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 9523 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1893 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41754 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 1892 | 0.010 |
Why?
|
| Antioxidants | 1 | 2002 | 1673 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6231 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 171504 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5210 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6082 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4568 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4627 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9343 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3603 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 10099 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7876 | 0.000 |
Why?
|
| Inflammation | 1 | 2002 | 10873 | 0.000 |
Why?
|